Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

The paper's citation list
No.The paper's citation list
1New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy. 2021;9:61 doi: 10.1002/ccr3.3418
2Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. 2019;27:383 doi: 10.1007/s00520-018-4501-x
3Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. 2019;127:117 doi: 10.1016/j.oooo.2018.09.008
4Risk factors for medication-related osteonecrosis of the jaws: A systematic review. 2018;24:527 doi: 10.1111/odi.12708
5Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. 2018;125:440 doi: 10.1016/j.oooo.2018.02.003
6Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents. 2020;26:955 doi: 10.1111/odi.13294
7Medication-related osteonecrosis of the jaw – a scoping review. 2022;333:1291 doi: 10.1097/FAD.0000000000000061
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties